Nanoligent vs RS Research
Nanoligent
Our mision is to improve the life of patients by designing new drugs that selectively target affected cells by disease
15 employees · est. 2017 · Spain
RS Research
Clinically-validated biotech company for targeted therapies, disrupting the efficacy-toxicity trade-off
30 employees · est. 2015 · Istanbul, Turkey
RS Research is the older company (2017 vs 2015).
2 signals in the last 90 days
Side-by-Side Comparison
| Metric | Nanoligent | RS Research |
|---|---|---|
| Founded | ||
| Founded | 2017 | 2015 older |
| Headquarters | ||
| Headquarters | Spain | Istanbul, Turkey |
| Employees | ||
| Employees | 15 | 30 |
| Industry | ||
| Industry | Biotechnology, Pharmaceutical | Biotechnology, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Seed | Series A |
| Total Funding | ||
| Total Funding | $2.80M | $14.00M |
| Funding Rounds | ||
| Funding Rounds | 2 | 4 |
| Services | ||
| Services | Not tracked yet | Development of targeted oncology therapies, Sagitta® drug delivery platform, Clinical trials for cancer treatment |
| Target Customers | ||
| Target Customers | Not tracked yet | Oncologists, Pharmaceutical companies, Research institutions, Healthcare providers |
| Taxonomy | ||
| Taxonomy | BiotechDrug DesignNanobiotechnologyCancer TreatmentMetastasisProtein Engineering +9 | Clinical-stage BiotechnologySmart NanomedicinesTargeted ChemotherapyDrug Delivery PlatformSagitta®Cancer Therapy +9 |
| Website | ||
| Website | nanoligent.com | rsresearch.net |
About Nanoligent
Nanoligent is a Spanish biotechnology and pharmaceutical startup founded in 2017, with a mission to improve the lives of patients by developing new drugs that selectively target cells affected by disease. Their innovative approach utilizes state-of-the-art protein engineering and nanobiotechnology t...
About RS Research
RS Research is a clinical-stage biotechnology start-up headquartered in Turkey that is at the forefront of developing smart nanomedicines for targeted chemotherapy. Established in 2015, the company leverages its innovative drug delivery platform, Sagitta®, aiming to provide a “Cure With a Smile” thr...
Also comparing in this category
Comparing more than these two?
Get Nanoligent, RS Research and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does Nanoligent compare?
A PDF of Nanoligent and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Rival Readout
Comparing competitors? We do this properly.
10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.
Frequently Asked Questions
Compare Nanoligent with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Nanoligent on 12 Sep 2024, and RS Research on 4 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.